Jie Zhou and Anika Singanayagam on their SARS-CoV-2 human challenge study

FromThe Lancet Microbe in conversation with

Start listening View podcast show

Jie Zhou and Anika Singanayagam on their SARS-CoV-2 human challenge study

FromThe Lancet Microbe in conversation with

ratings:

Length:

20 minutes

Released:

Jun 9, 2023

Format:

Podcast episode

Description

Elena Dalla Vecchia of The Lancet Microbe speaks to Dr Jie Zhou and Dr Anika Singanayagam about their SARS-CoV-2 human challenge study.Read the full article:https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(23)00101-5/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanmic

Released:

Jun 9, 2023

Format:

Podcast episode

Titles in the series (13)

Our Editors and the journal’s authors explore their research and its impact on people’s health, health care, and health policy in this regular podcast.

Skip carousel

Adrian Martineau on Mycobacterium tuberculosis in Ethiopia by The Lancet Microbe in conversation with
13 min listen
Samuel Lipworth on Mycobacterium abscessus by The Lancet Microbe in conversation with
12 min listen
Hanna Ehrlich on antimalarial drug resistance surveillance by The Lancet Microbe in conversation with
31 min listen
Michael Otto on using probiotics to reduce Staphylococcus aureus by The Lancet Microbe in conversation with
20 min listen
Nichola Calvani on gender equity in science by The Lancet Microbe in conversation with
21 min listen
David Cameron on phage therapy by The Lancet Microbe in conversation with
9 min listen
Fabrice Somé sur la surveillance de la résistance aux médicaments antipaludiques (en français) by The Lancet Microbe in conversation with
31 min listen
Jie Zhou and Anika Singanayagam on their SARS-CoV-2 human challenge study by The Lancet Microbe in conversation with
20 min listen
Erica Furhmeister on monitoring antimicrobial resistance using faecal metagenomes by The Lancet Microbe in conversation with
19 min listen
Kate Baker on harnessing genomics for antimicrobial resistance surveillance by The Lancet Microbe in conversation with
19 min listen
Deborah Williamson and Michael Moso on detecting on-SARS-CoV-2 viruses from COVID-19 rapid antigen test devices by The Lancet Microbe in conversation with
19 min listen
Martin Hoenigl on climate change and fungal diseases by The Lancet Microbe in conversation with
35 min listen
Nancy Chow on sporotrichosis by The Lancet Microbe in conversation with
21 min listen

More Episodes from The Lancet Microbe in conversation with

Skip carousel

Martin Hoenigl on climate change and fungal diseases by The Lancet Microbe in conversation with
35 min listen
Nancy Chow on sporotrichosis by The Lancet Microbe in conversation with
21 min listen
Deborah Williamson and Michael Moso on detecting on-SARS-CoV-2 viruses from COVID-19 rapid antigen test devices by The Lancet Microbe in conversation with
19 min listen
Kate Baker on harnessing genomics for antimicrobial resistance surveillance by The Lancet Microbe in conversation with
19 min listen
Erica Furhmeister on monitoring antimicrobial resistance using faecal metagenomes by The Lancet Microbe in conversation with
19 min listen
Hanna Ehrlich on antimalarial drug resistance surveillance by The Lancet Microbe in conversation with
31 min listen
Fabrice Somé sur la surveillance de la résistance aux médicaments antipaludiques (en français) by The Lancet Microbe in conversation with
31 min listen
Nichola Calvani on gender equity in science by The Lancet Microbe in conversation with
21 min listen
Michael Otto on using probiotics to reduce Staphylococcus aureus by The Lancet Microbe in conversation with
20 min listen
David Cameron on phage therapy by The Lancet Microbe in conversation with
9 min listen
Samuel Lipworth on Mycobacterium abscessus by The Lancet Microbe in conversation with
12 min listen
Adrian Martineau on Mycobacterium tuberculosis in Ethiopia by The Lancet Microbe in conversation with
13 min listen

Related podcast episodes

Skip carousel

Hanna Ehrlich on antimalarial drug resistance surveillance by The Lancet Microbe in conversation with
31 min listen
Freely Filtered 014 COVID-19 Podcast No. 2 by Freely Filtered, a NephJC Podcast
56 min listen
Cecilia Åkerlund and David Nelson on prognosis of traumatic brain injury by The Lancet Neurology in conversation with
18 min listen
Prasad Kulkarni on dengue monoclonal antibodies by The Lancet Infectious Diseases in conversation with
19 min listen
The latest long COVID research on symptoms, testing and treatments with Akiko Iwasaki, PhD: Leading long COVID researcher, Akiko Iwasaki, PhD, sterling professor of immunobiology at Yale University, joins to provide an update on the latest long COVID studies and clinical trials—and what their findings mean for physicians and patients. Dr. Iwasaki discusses what we know now about the causes of long COVID, the ongoing challenges with diagnosing it and the timeline for potential treatments. American Medical Association CXO Todd Unger hosts. ?️ Watch Dr. Iwasaki's previous episode here: https://youtu.be/kONtiiHsbPw?si=TMIr95DMfvuYDF3f ? Distinguishing features of long COVID identified through immune profiling published in Nature: https://www.nature.com/articles/s41586-023-06651-y ? Scientists Offer a New Explanation for Long Covid New York Times article: https://www.nytimes.com/2023/10/16/health/long-covid-serotonin.html ? The AMA is your powerful ally in patient care. Join now: https: by AMA Update
14 min listen
Fabrice Somé sur la surveillance de la résistance aux médicaments antipaludiques (en français) by The Lancet Microbe in conversation with
31 min listen
Around The Scope: Pathology in a Cyberattack: In this series, PathPod gathers pathologists Around The Scope to discuss topics in depth. Today, we hear about the role of the laboratory and IT in navigating a cyberattack. Our host, Dr. Sara Jiang (@Sara_Jiang) speaks with Dr. Joanna Conant (@joconantm... by The PathPod Podcast
51 min listen
Get ready for the return of lockdowns. Is this the right way to deal with COVID? With Kirk Parsley, MD: Kirk Parsley served as an Undersea Medical Officer at Naval Special Warfare Group One from June 2009 to January 2013. While there, he led the development and supervised the group’s first Sports Medicine Rehabilitation center. He is a former SEAL,... by Paul Saladino MD podcast
109 min listen
COVID-19 Diagnostic Testing Redux (JCM ed.): Laboratory testing for COVID-19, what’s new since we talked about this in August? A lot. Here are some of the questions we’ll talk about. • Do positive antibody tests indicate that people are immune to infection by SARS-CoV-2, the virus that... by Editors in Conversation
48 min listen
Florian Krammer - COVID-19 Vaccine Development by Hopkins Biotech Podcast
59 min listen
David J Pinato on SARS-CoV-2 omicron outcomes among patients with cancer by The Lancet Oncology in conversation with
5 min listen
COVID-19: Evolution of the SARS-CoV-2 virus: What is the latest information on the SARS-CoV-2 virus variants? How is WHO tracking these virus mutations globally and how do we know which ones are important? Answering these questions in this episode of Science in 5 is WHO's expert Dr. Maria Van... by Science in 5
5 min listen
Journal Club: Why do only some people get severe COVID-19? by Raising Health
28 min listen
Equity, Diversity and Inclusion in science (Part 1): Short description: Our special bonus episode on equality & diversity in science. Guests: Sabrina Fleurimé (BBSTEM), Prof. Iruka Okeke, Prof. Eva Maria C. Cutiongco-de la Paz and Prof. Collet Dandara. Soundbite: Dr. Yolanda Ohene Episode description: This is a special bonus episode on equity & diversity. In it we interview some amazing guests that talk about their personal experience and where as an industry things need to change. Covered in the topics is, representation matters, ensuring equity from the beginning, in academic research practices and the role institutions play in addressing diversity and inclusion. This episode is in two parts. by Your Digital Mentor Podcast
85 min listen
Estimating excess deaths from Covid-19: In this episode of the Heart podcast, Digital Med… by Heart podcast
25 min listen
COVID-19 Data and Non-coding RNA Impact Factors: What Vinod Scaria Can Tell Us about the Numbers: While Vinod Scaria specializes in computational biology regarding , he's lab has diverted their energies to focus most of their data analysis specifically on the genomics of COVID-19. He gives listeners a global picture of the data and also explains... by Finding Genius Podcast
27 min listen
Coronapod: Infected immune cells hint at cause of severe COVID by Nature Podcast
11 min listen
SARS-CoV-2 Sequencing for Clinical Care and Infection Control: Is sequencing the SARS-CoV-2 genome useful for patient care? What about institutional infection control? And if clinical labs decide to perform SARS-CoV-2 sequencing, how should they do it? How should they report the results? And will they get paid?... by Editors in Conversation
50 min listen
Covid -19 new hope from blood tests: Research from New York shows how our own immune response is responding to Covid 19 by Unexpected Elements
75 min listen
Caution Needed on the Use of Chloroquine and Hydroxychloroquine for Coronavirus Disease 2019: Steven M. Bradley, MD, MPH joins JAMA Network editors to discuss a randomized clinical trial evaluating the safety and efficacy of 2 chloroquine diphosphate dosages in patients with severe coronavirus disease 2019 (COVID-19). Read the editorial here: ... by JAMA Network Open Conversations
15 min listen
Caution Needed on the Use of Chloroquine and Hydroxychloroquine for Coronavirus Disease 2019: Steven M. Bradley, MD, MPH joins JAMA Network editors to discuss a randomized clinical trial evaluating the safety and efficacy of 2 chloroquine diphosphate dosages in patients with severe coronavirus disease 2019 (COVID-19). Read the editorial here: ... by Coronavirus (COVID-19) Q&A
15 min listen
mRNA Vaccine Mechanism, Safety, Communication: Two mRNA vaccines have been approved to lead the fight against COVID19. Both have been rapidly approved with Emergency Use Authorization, which does not build public trust. Ultimately compelling the vaccine hesitant to receive the vaccination may be the m by Talking Biotech with Dr. Kevin Folta
77 min listen
Jessica Rose: Adverse Events Reporting and Much More: In this episode, I have a fascinating 3-hour conversation with Dr. Jessica Rose about all things related to C-word juices, ranging from interpreting the adverse event reporting system to the future of mandatory prophylactic gene therapy. If you... by Mastering Nutrition
190 min listen
MWV Episode 48 - Emerging Diseases: The Importance of Early Warning and Surveillance Systems: Interview with Stephen S. Morse, Ph.D. by MicrobeWorld Video
10 min listen
The Epigenetics of Aging & Dispelling mRNA Vaccine Myths with Yuri Deigin by The External Medicine Podcast
56 min listen
Cutaneous clinical signs of COVID-19: COVID-19 affects multiple organ systems, and skin manifestations are prevalent. Dr. Vincent DeLeo talks to medical student Lauren Schwartzberg and Ann Lin, DO, about both common and rare cutaneous presentations of COVID-19. “I think it’s important... by Dermatology Weekly
10 min listen
DrBeen#22 SARS-COV-2 Persists in Almost All Tissues of The Body for Month by FLCCC Alliance
33 min listen
DrBeen#80 New Yale Study Shows Vaccine Injured Are Highly Symptomatic with Poor Health (Preprint) by FLCCC Alliance
24 min listen
European Perspectives on Advances in HIV Treatment: This podcast episode features European perspectives on some of the most important new antiretroviral therapy insights from HIV research over the past year, including findings from real-world and long-term studies of 2-drug oral regimens, the latest on 2-drug long-acting injectable therapy, and other new and emerging innovations in HIV treatment. by CCO Infectious Disease Podcast
22 min listen
Episode 35: October 2023: The JHLT Digital Media Editors explore two manuscripts from the October issue of The Journal of Heart and Lung Transplantation—the first on lung transplantation in patients with stacked risks, and the second on bacterial pathogens found at driveline... by JHLT: The Podcast
20 min listen

Discover this podcast and so much more

Jie Zhou and Anika Singanayagam on their SARS-CoV-2 human challenge study

Jie Zhou and Anika Singanayagam on their SARS-CoV-2 human challenge study

Description

Titles in the series (13)

More Episodes from The Lancet Microbe in conversation with

Related podcast episodes